Skin Integrity Team has been shortlisted in three categories at this year’s Journal of Wound Care Awards, which take place ...

Take steps to improve blood flow to legs and help prevent venous conditions such as varicose and spider veins. Suggestions ...

MediWound has commenced a pivotal, multicentre Phase III VALUE trial to assess its bioactive debridement therapy, EscharEx, ...

MediWound, an Israeli developer of products to treat burns and wounds using non-surgical tissue repair, said on Wednesday it ...

MediWound (NASDAQ:MDWD) stock climbed 4% following news that the company has initiated a Phase 3 study of its wound care product EscharEX in the treatment of venous leg ulcers, or VLU. The company ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure Interim analysis planned after 65% of patients complete treatment, expected in ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure ...

Alcohol-related deaths increased 18% during the pandemic, as did hospitalizations related to alcohol use, according to new ...